Get the Stockscreener App
30.85
1.02%
0.31
Pre-market:
30.61
-0.24
-0.78%
Grail Inc stock is traded at $30.85, with a volume of 1.39M.
It is up +1.02% in the last 24 hours and down -21.42% over the past month.
GRAIL Inc is a healthcare company focused on developing technologies for early cancer detection. The company has developed a multi-cancer early detection blood test that has the ability to detect all types of cancer, across all stages. It operates in one reportable operating segment which provides multi-cancer early detection testing and service.
See More
Previous Close:
$30.54
Open:
$31.1
24h Volume:
1.39M
Relative Volume:
0.99
Market Cap:
$1.05B
Revenue:
$117.67M
Net Income/Loss:
$-1.88B
P/E Ratio:
-0.5096
EPS:
-60.5369
Net Cash Flow:
$-621.36M
1W Performance:
-19.45%
1M Performance:
-21.42%
6M Performance:
+127.68%
1Y Performance:
+0.00%
1-Day Range:
$29.32
$32.18
1-Week Range:
$29.02
$38.09
52-Week Range:
$12.33
$63.99
Grail Inc Stock (GRAL) Company Profile
Name
Grail Inc
Sector
Industry
Phone
(833) 694-2553
Address
1525 O'BRIEN DRIVE, MENLO PARK
Compare GRAL with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
GRAL
Grail Inc
|
30.85 | 1.05B | 117.67M | -1.88B | -621.36M | -60.54 |
|
TMO
Thermo Fisher Scientific Inc
|
512.65 | 193.40B | 42.88B | 6.34B | 7.27B | 16.53 |
|
DHR
Danaher Corp
|
204.96 | 146.49B | 23.88B | 3.90B | 5.30B | 5.28 |
|
A
Agilent Technologies Inc
|
119.85 | 34.19B | 6.53B | 1.26B | 1.31B | 4.35 |
|
IDXX
Idexx Laboratories Inc
|
412.40 | 33.54B | 3.90B | 887.87M | 798.08M | 10.67 |
|
IQV
Iqvia Holdings Inc
|
185.42 | 32.69B | 15.41B | 1.37B | 2.11B | 7.50 |
Grail Inc Stock (GRAL) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-27-24 | Initiated | Morgan Stanley | Equal-Weight |
| Nov-15-24 | Initiated | Wolfe Research | Peer Perform |
| Oct-17-24 | Initiated | Guggenheim | Neutral |
Grail Inc Stock (GRAL) Latest News
Grail CEO Robert Ragusa sells $237,976 in stock - Investing.com India
Grail president Joshua Ofman sells $65,800 in common stock - Investing.com
Grail CEO Robert Ragusa sells $237,976 in stock By Investing.com - Investing.com UK
Oppenheimer & Co. Inc. Invests $190,000 in Grail, Inc. (NASDAQ:GRAL) - Defense World
Rhumbline Advisers Makes New Investment in Grail, Inc. (NASDAQ:GRAL) - Defense World
New York State Common Retirement Fund Makes New $59,000 Investment in Grail, Inc. (NASDAQ:GRAL) - Defense World
GRALGrail Inc Latest Stock News & Market Updates - StockTitan
Is GRAIL, Inc. (GRAL) Among Jeff Bezos’ Investments in 2025? - Yahoo Finance
Jeff Bezos Investments in 2025: 12 Companies Bezos Is Investing In - Insider Monkey
Ieq Capital LLC Acquires Shares of 19,874 Grail, Inc. (NASDAQ:GRAL) - MarketBeat
Grail (NASDAQ:GRAL) Trading 9.8% HigherWhat's Next? - MarketBeat
GRAIL Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - PR Newswire
Grail goes 'Grey's': Actor Kate Walsh joins awareness campaign for multi-cancer early detection testing - FiercePharma
GRAIL Partners With Actress Kate Walsh for Generation Possible to Raise Awareness of Multi-Cancer Early Detection Testing - Longview News-Journal
Grail projects FDA submission completion for Galleri by H1 2026 with expanded scalability - MSN
Can This New Cancer Test Detect 70% of Deadly Cancers Before It's Too Late? - StockTitan
GRAIL, Inc. (GRAL): Among the Best Performing Small Cap Stocks So Far In 2025 - Insider Monkey
C2P Capital Advisory Group LLC d.b.a. Prosperity Capital Advisors Makes New $244,000 Investment in Grail, Inc. (NASDAQ:GRAL) - MarketBeat
Why Grail (GRAL) Is Falling Today - MSN
Van ECK Associates Corp Takes $475,000 Position in Grail, Inc. (NASDAQ:GRAL) - Defense World
Grail initiated at equal weight by Morgan Stanley - MSN
Can GRAIL's Cancer Detection Technology Transform Healthcare? Key Presentation Coming March 4 - StockTitan
Putting early cancer detection to the test - Nature.com
GRAIL Q4 Loss Narrows, Revenue Up; Shares Rise After-Hours -February 20, 2025 at 05:36 pm EST - Marketscreener.com
Earnings call transcript: Grail’s Q4 2024 revenue rises, stock surges - Investing.com
Earnings call transcript: Grail’s Q4 2024 revenue rises, stock surges By Investing.com - Investing.com Nigeria
Grail reports Q4 EPS ($2.89) vs. ($6.04) last year - TipRanks
Earnings call transcript: Grail's Q4 2024 revenue rises, stock surges By Investing.com - Investing.com UK
GRAIL Reports Fourth Quarter and Full Year 2024 Financial Results - TradingView
Earnings Flash (GRAL) GRAIL INC. Posts Q4 Revenue $38.3M, vs. FactSet Est of $34.4M - Marketscreener.com
Can GRAIL's 137,000 Cancer Test Sales Overcome Its $2B Loss? Key Earnings Insights - StockTitan
Grail Inc options imply 13.5% move in share price post-earnings - TipRanks
Golden Grail Beverages Announces Termination of UPDC Beverages Asset Purchase Agreement - GlobeNewswire
Investors Eye Biotech Sector as Cancer Therapy Market Surges - The Globe and Mail
We're Keeping An Eye On GRAIL's (NASDAQ:GRAL) Cash Burn Rate - Yahoo Finance
Grail Inc expected to post a loss of $7.05 a shareEarnings Preview - TradingView
Grail, Inc. (NASDAQ:GRAL) Short Interest Update - Defense World
Grail rallies 30% in wake of Quest agreement - MSN
Grail (NASDAQ:GRAL) Trading 5.4% HigherWhat's Next? - MarketBeat
Moloney Securities Asset Management LLC Invests $559,000 in Grail, Inc. (NASDAQ:GRAL) - MarketBeat
Grail shares jump on partnership with Quest Diagnostics - Mugglehead
GRAIL teams up with Quest to widen access to Galleri cancer test - MSN
abrdn plc Purchases Shares of 211,068 Grail, Inc. (NASDAQ:GRAL) - MarketBeat
Grail rallies 30% in wake of Quest agreement (GRAL:NASDAQ) - Seeking Alpha
Grail distribution partnership with Quest a positive, says Guggenheim - TipRanks
Grail and Quest Diagnostics to offer Galleri test to US physicians - Yahoo
Grail (NASDAQ:GRAL) Reaches New 12-Month HighWhat's Next? - MarketBeat
Grail Inc Stock (GRAL) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.20%
1.03%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):